4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006735
SVP, Chief Commercial Officer acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wessels Gregory S. SVP, Chief Commercial Officer | 2021-02-25 | Grant or award | +16,000 | 16,000 | D | ||
| Derivatives | |||||||
| Wessels Gregory S. SVP, Chief Commercial Officer | 2021-02-25 | Grant or award · Stock Option (right to Buy) | +66,000 | 66,000 | D | ||
Loading xslF345X03/form4.xml…